Loading…

Maternal death after oocyte donation at high maternal age: case report

The percentage of women giving birth after the age of 35 increased in many western countries. The number of women remaining childless also increased, mostly due to aging oocytes. The method of oocyte donation offers the possibility for infertile older women to become pregnant. Gestation after oocyte...

Full description

Saved in:
Bibliographic Details
Published in:Reproductive health 2008-12, Vol.5 (1), p.12-12, Article 12
Main Authors: Schutte, Joke M, Schuitemaker, Nico W E, Steegers, Eric A P, van Roosmalen, Jos
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93
cites cdi_FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93
container_end_page 12
container_issue 1
container_start_page 12
container_title Reproductive health
container_volume 5
creator Schutte, Joke M
Schuitemaker, Nico W E
Steegers, Eric A P
van Roosmalen, Jos
description The percentage of women giving birth after the age of 35 increased in many western countries. The number of women remaining childless also increased, mostly due to aging oocytes. The method of oocyte donation offers the possibility for infertile older women to become pregnant. Gestation after oocyte-donation-IVF, however, is not without risks for the mother, especially at advanced age. An infertile woman went abroad for oocyte-donation-IVF, since this treatment is not offered in The Netherlands after the age of 45. The first oocyte donation treatment resulted in multiple gestation, but was ended by induced abortion: the woman could not cope with the idea of being pregnant with twins. During the second pregnancy after oocyte donation, at the age of 50, she was mentally more stable. The pregnancy, again a multiple gestation, was uneventful until delivery. Immediately after delivery the woman had hypertension with nausea and vomiting. A few hours later she had an eclamptic fit. HELLP-syndrome was diagnosed. She died due to cerebral haemorrhage. In The Netherlands, the age limit for women receiving donor oocytes is 45 years and commercial oocyte donation is forbidden by law. In other countries there is no age limit, the reason why some women are going abroad to receive the treatment of their choice. Advanced age, IVF and twin pregnancy are all risk factors for pre-eclampsia, the leading cause of maternal death in The Netherlands.Patient autonomy is an important ethical principle, but doctors are also bound to the principle of 'not doing harm', and do have the right to refuse medical treatment such as IVF-treatment. The discussion whether women above 50 should have children is still not closed. If the decision is made to offer this treatment to a woman at advanced age, the doctor should counsel her intensively about the risks before treatment is started.
doi_str_mv 10.1186/1742-4755-5-12
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_570c59fab59944a3b1f20906021e859f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A191829719</galeid><doaj_id>oai_doaj_org_article_570c59fab59944a3b1f20906021e859f</doaj_id><sourcerecordid>A191829719</sourcerecordid><originalsourceid>FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93</originalsourceid><addsrcrecordid>eNp1kkFv1DAQhSMEoqVw5YgiceCU1mPHccwBaVVRqFTUC5ytsTPJukrixclW6r_HYbelqxb5YM-850_jGWfZe2CnAHV1BqrkRamkLGQB_EV2_JB4-eh8lL2ZphvGBNRMvc6OQANUKTzOLn7gTHHEPm8I53WObQrzENzdTHkTRpx9GHOc87Xv1vlwb8aOPucOJ8ojbUKc32avWuwnerffT7JfF19_nn8vrq6_XZ6vrgorK-CFswJ0KW3LayEY6YakKGsOVlrGmKsUq6qqxrpFK4WSSdCCN7bUDhW2jRYn2eWO2wS8MZvoB4x3JqA3fxMhdgbj7F1PRirmpF5IWpclCgstZ5pVjAPVSUisLzvWZmsHahyNc8T-AHqojH5tunBreAVSlSIBVjuA9eE_gEPFhcEsMzHLTIw0wBPj076IGH5vaZrN4CdHfY8jhe1klCihlqAgOT_unB2m1_mxDYnpFrdZpXnWXCtYGnT6jCuthgbvwkitT_nnLrgYpilS-1A_MLN8sacVf3jctn_2_Z8SfwDMZsnD</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734185171</pqid></control><display><type>article</type><title>Maternal death after oocyte donation at high maternal age: case report</title><source>PubMed (Medline)</source><creator>Schutte, Joke M ; Schuitemaker, Nico W E ; Steegers, Eric A P ; van Roosmalen, Jos</creator><creatorcontrib>Schutte, Joke M ; Schuitemaker, Nico W E ; Steegers, Eric A P ; van Roosmalen, Jos ; Dutch Maternal Mortality Committee ; the Dutch Maternal Mortality Committee</creatorcontrib><description>The percentage of women giving birth after the age of 35 increased in many western countries. The number of women remaining childless also increased, mostly due to aging oocytes. The method of oocyte donation offers the possibility for infertile older women to become pregnant. Gestation after oocyte-donation-IVF, however, is not without risks for the mother, especially at advanced age. An infertile woman went abroad for oocyte-donation-IVF, since this treatment is not offered in The Netherlands after the age of 45. The first oocyte donation treatment resulted in multiple gestation, but was ended by induced abortion: the woman could not cope with the idea of being pregnant with twins. During the second pregnancy after oocyte donation, at the age of 50, she was mentally more stable. The pregnancy, again a multiple gestation, was uneventful until delivery. Immediately after delivery the woman had hypertension with nausea and vomiting. A few hours later she had an eclamptic fit. HELLP-syndrome was diagnosed. She died due to cerebral haemorrhage. In The Netherlands, the age limit for women receiving donor oocytes is 45 years and commercial oocyte donation is forbidden by law. In other countries there is no age limit, the reason why some women are going abroad to receive the treatment of their choice. Advanced age, IVF and twin pregnancy are all risk factors for pre-eclampsia, the leading cause of maternal death in The Netherlands.Patient autonomy is an important ethical principle, but doctors are also bound to the principle of 'not doing harm', and do have the right to refuse medical treatment such as IVF-treatment. The discussion whether women above 50 should have children is still not closed. If the decision is made to offer this treatment to a woman at advanced age, the doctor should counsel her intensively about the risks before treatment is started.</description><identifier>ISSN: 1742-4755</identifier><identifier>EISSN: 1742-4755</identifier><identifier>DOI: 10.1186/1742-4755-5-12</identifier><identifier>PMID: 19116003</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Age ; Case Report ; Case studies ; Complications and side effects ; Fertilization in vitro ; Health aspects ; Mothers ; Oocyte donation ; Patient outcomes ; Preeclampsia ; Pregnancy, Complications of ; Risk factors</subject><ispartof>Reproductive health, 2008-12, Vol.5 (1), p.12-12, Article 12</ispartof><rights>COPYRIGHT 2008 BioMed Central Ltd.</rights><rights>Copyright © 2008 Schutte et al; licensee BioMed Central Ltd. 2008 Schutte et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93</citedby><cites>FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615743/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615743/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19116003$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schutte, Joke M</creatorcontrib><creatorcontrib>Schuitemaker, Nico W E</creatorcontrib><creatorcontrib>Steegers, Eric A P</creatorcontrib><creatorcontrib>van Roosmalen, Jos</creatorcontrib><creatorcontrib>Dutch Maternal Mortality Committee</creatorcontrib><creatorcontrib>the Dutch Maternal Mortality Committee</creatorcontrib><title>Maternal death after oocyte donation at high maternal age: case report</title><title>Reproductive health</title><addtitle>Reprod Health</addtitle><description>The percentage of women giving birth after the age of 35 increased in many western countries. The number of women remaining childless also increased, mostly due to aging oocytes. The method of oocyte donation offers the possibility for infertile older women to become pregnant. Gestation after oocyte-donation-IVF, however, is not without risks for the mother, especially at advanced age. An infertile woman went abroad for oocyte-donation-IVF, since this treatment is not offered in The Netherlands after the age of 45. The first oocyte donation treatment resulted in multiple gestation, but was ended by induced abortion: the woman could not cope with the idea of being pregnant with twins. During the second pregnancy after oocyte donation, at the age of 50, she was mentally more stable. The pregnancy, again a multiple gestation, was uneventful until delivery. Immediately after delivery the woman had hypertension with nausea and vomiting. A few hours later she had an eclamptic fit. HELLP-syndrome was diagnosed. She died due to cerebral haemorrhage. In The Netherlands, the age limit for women receiving donor oocytes is 45 years and commercial oocyte donation is forbidden by law. In other countries there is no age limit, the reason why some women are going abroad to receive the treatment of their choice. Advanced age, IVF and twin pregnancy are all risk factors for pre-eclampsia, the leading cause of maternal death in The Netherlands.Patient autonomy is an important ethical principle, but doctors are also bound to the principle of 'not doing harm', and do have the right to refuse medical treatment such as IVF-treatment. The discussion whether women above 50 should have children is still not closed. If the decision is made to offer this treatment to a woman at advanced age, the doctor should counsel her intensively about the risks before treatment is started.</description><subject>Age</subject><subject>Case Report</subject><subject>Case studies</subject><subject>Complications and side effects</subject><subject>Fertilization in vitro</subject><subject>Health aspects</subject><subject>Mothers</subject><subject>Oocyte donation</subject><subject>Patient outcomes</subject><subject>Preeclampsia</subject><subject>Pregnancy, Complications of</subject><subject>Risk factors</subject><issn>1742-4755</issn><issn>1742-4755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp1kkFv1DAQhSMEoqVw5YgiceCU1mPHccwBaVVRqFTUC5ytsTPJukrixclW6r_HYbelqxb5YM-850_jGWfZe2CnAHV1BqrkRamkLGQB_EV2_JB4-eh8lL2ZphvGBNRMvc6OQANUKTzOLn7gTHHEPm8I53WObQrzENzdTHkTRpx9GHOc87Xv1vlwb8aOPucOJ8ojbUKc32avWuwnerffT7JfF19_nn8vrq6_XZ6vrgorK-CFswJ0KW3LayEY6YakKGsOVlrGmKsUq6qqxrpFK4WSSdCCN7bUDhW2jRYn2eWO2wS8MZvoB4x3JqA3fxMhdgbj7F1PRirmpF5IWpclCgstZ5pVjAPVSUisLzvWZmsHahyNc8T-AHqojH5tunBreAVSlSIBVjuA9eE_gEPFhcEsMzHLTIw0wBPj076IGH5vaZrN4CdHfY8jhe1klCihlqAgOT_unB2m1_mxDYnpFrdZpXnWXCtYGnT6jCuthgbvwkitT_nnLrgYpilS-1A_MLN8sacVf3jctn_2_Z8SfwDMZsnD</recordid><startdate>20081230</startdate><enddate>20081230</enddate><creator>Schutte, Joke M</creator><creator>Schuitemaker, Nico W E</creator><creator>Steegers, Eric A P</creator><creator>van Roosmalen, Jos</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20081230</creationdate><title>Maternal death after oocyte donation at high maternal age: case report</title><author>Schutte, Joke M ; Schuitemaker, Nico W E ; Steegers, Eric A P ; van Roosmalen, Jos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Age</topic><topic>Case Report</topic><topic>Case studies</topic><topic>Complications and side effects</topic><topic>Fertilization in vitro</topic><topic>Health aspects</topic><topic>Mothers</topic><topic>Oocyte donation</topic><topic>Patient outcomes</topic><topic>Preeclampsia</topic><topic>Pregnancy, Complications of</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schutte, Joke M</creatorcontrib><creatorcontrib>Schuitemaker, Nico W E</creatorcontrib><creatorcontrib>Steegers, Eric A P</creatorcontrib><creatorcontrib>van Roosmalen, Jos</creatorcontrib><creatorcontrib>Dutch Maternal Mortality Committee</creatorcontrib><creatorcontrib>the Dutch Maternal Mortality Committee</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Reproductive health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schutte, Joke M</au><au>Schuitemaker, Nico W E</au><au>Steegers, Eric A P</au><au>van Roosmalen, Jos</au><aucorp>Dutch Maternal Mortality Committee</aucorp><aucorp>the Dutch Maternal Mortality Committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maternal death after oocyte donation at high maternal age: case report</atitle><jtitle>Reproductive health</jtitle><addtitle>Reprod Health</addtitle><date>2008-12-30</date><risdate>2008</risdate><volume>5</volume><issue>1</issue><spage>12</spage><epage>12</epage><pages>12-12</pages><artnum>12</artnum><issn>1742-4755</issn><eissn>1742-4755</eissn><abstract>The percentage of women giving birth after the age of 35 increased in many western countries. The number of women remaining childless also increased, mostly due to aging oocytes. The method of oocyte donation offers the possibility for infertile older women to become pregnant. Gestation after oocyte-donation-IVF, however, is not without risks for the mother, especially at advanced age. An infertile woman went abroad for oocyte-donation-IVF, since this treatment is not offered in The Netherlands after the age of 45. The first oocyte donation treatment resulted in multiple gestation, but was ended by induced abortion: the woman could not cope with the idea of being pregnant with twins. During the second pregnancy after oocyte donation, at the age of 50, she was mentally more stable. The pregnancy, again a multiple gestation, was uneventful until delivery. Immediately after delivery the woman had hypertension with nausea and vomiting. A few hours later she had an eclamptic fit. HELLP-syndrome was diagnosed. She died due to cerebral haemorrhage. In The Netherlands, the age limit for women receiving donor oocytes is 45 years and commercial oocyte donation is forbidden by law. In other countries there is no age limit, the reason why some women are going abroad to receive the treatment of their choice. Advanced age, IVF and twin pregnancy are all risk factors for pre-eclampsia, the leading cause of maternal death in The Netherlands.Patient autonomy is an important ethical principle, but doctors are also bound to the principle of 'not doing harm', and do have the right to refuse medical treatment such as IVF-treatment. The discussion whether women above 50 should have children is still not closed. If the decision is made to offer this treatment to a woman at advanced age, the doctor should counsel her intensively about the risks before treatment is started.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>19116003</pmid><doi>10.1186/1742-4755-5-12</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1742-4755
ispartof Reproductive health, 2008-12, Vol.5 (1), p.12-12, Article 12
issn 1742-4755
1742-4755
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_570c59fab59944a3b1f20906021e859f
source PubMed (Medline)
subjects Age
Case Report
Case studies
Complications and side effects
Fertilization in vitro
Health aspects
Mothers
Oocyte donation
Patient outcomes
Preeclampsia
Pregnancy, Complications of
Risk factors
title Maternal death after oocyte donation at high maternal age: case report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A22%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maternal%20death%20after%20oocyte%20donation%20at%20high%20maternal%20age:%20case%20report&rft.jtitle=Reproductive%20health&rft.au=Schutte,%20Joke%20M&rft.aucorp=Dutch%20Maternal%20Mortality%20Committee&rft.date=2008-12-30&rft.volume=5&rft.issue=1&rft.spage=12&rft.epage=12&rft.pages=12-12&rft.artnum=12&rft.issn=1742-4755&rft.eissn=1742-4755&rft_id=info:doi/10.1186/1742-4755-5-12&rft_dat=%3Cgale_doaj_%3EA191829719%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b5612-cb31945bf28330e9de534821b5b000c6706668a8fab537521b932db49ca7afd93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734185171&rft_id=info:pmid/19116003&rft_galeid=A191829719&rfr_iscdi=true